Jiangsu Aidea Pharmaceutical Group Co., Ltd. (SHA:688488)
China · Delayed Price · Currency is CNY 15.51
-0.51 (-3.18%)
Mar 30, 2026, 3:00 PM CST
SHA:688488 Market Cap
SHA:688488 has a market cap or net worth of 6.74 billion as of March 27, 2026. Its market cap has increased by 94.42% in one year.
Market Cap
6.74B
Enterprise Value
6.91B
Revenue
720.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
15.51
Market Cap Chart
Since July 20, 2020, SHA:688488's market cap has decreased from 12.99B to 6.74B, a decrease of -48.09%. That is a compound annual growth rate of -10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 6.74B | -1.90% |
| Dec 31, 2025 | 6.87B | 107.76% |
| Dec 31, 2024 | 3.31B | -37.17% |
| Dec 29, 2023 | 5.26B | 18.91% |
| Dec 30, 2022 | 4.43B | -32.31% |
| Dec 31, 2021 | 6.54B | -37.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 7.72B |
| Suzhou Fengbei Biotech Stock | 7.38B |
| Chengdu Kanghua Biological Products | 7.35B |
| Anhui Huaheng Biotechnology | 7.20B |
| Acrobiosystems | 7.09B |
| Wuhan Keqian Biology Co.,Ltd | 6.75B |
| Shenzhen Weiguang Biological Products | 6.17B |
| Xiangxue Pharmaceutical | 6.14B |